Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -714 | -4,243 | -3,862 | -475 | -257 |
| Depreciation Amortization | 11 | N/A | N/A | N/A | N/A |
| Income taxes - deferred | -96 | N/A | N/A | N/A | N/A |
| Accounts receivable | 3 | N/A | N/A | N/A | N/A |
| Other Working Capital | 229 | 2,602 | 2,347 | -585 | -609 |
| Other Operating Activity | 41 | 156 | 138 | 6 | 3 |
| Operating Cash Flow | $-526 | $-1,485 | $-1,377 | $-1,054 | $-862 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 313 | N/A | N/A | N/A | N/A |
| Debt Issued | 50 | 1,110 | 1,113 | 953 | 950 |
| Debt Repayment | -13 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 450 | 450 | 90 | 0 |
| Financing Cash Flow | $350 | $1,560 | $1,563 | $1,043 | $950 |
| Beginning Cash Position | 350 | 19 | 19 | 19 | 19 |
| End Cash Position | 174 | 93 | 205 | 8 | 106 |
| Net Cash Flow | $-176 | $75 | $186 | $-11 | $88 |
| Free Cash Flow | |||||
| Operating Cash Flow | -526 | -1,485 | -1,377 | -1,054 | -862 |
| Free Cash Flow | -526 | -1,485 | -1,377 | -1,054 | -862 |